
Baker McKenzie Advises Highbridge Capital Management, LLC on its Additional CHF 10 Million Investment in Santhera Pharmaceuticals via Convertible Bond | Newsroom
Baker McKenzie Switzerland advised certain funds managed by Highbridge Capital Management, LLC (“Highbridge”), a longstanding investor in Santhera Pharmaceuticals (SIX: SANN, “Santhera”), on its investment and commitment of an additional








